Superworth

Fennec Pharmaceuticals EPS FENC

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.11
Latest quarter, Q2 FY26
$0.05
Fiscal year 2025
−$0.32

Fennec Pharmaceuticals' earnings per share was −$0.11 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was $0.05.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.32n/a
FY2024−$0.07n/a
FY2023−$0.61n/a
FY2022−$0.90n/a
FY2021−$0.66n/a
FY2020−$0.77n/a
FY2019−$0.37n/a
FY2018−$0.52n/a
FY2017−$0.46n/a
FY2016−$0.22n/a
FY2015−$0.07n/a
FY2014−$0.24−250%
FY2013$0.16n/a
FY2012−$0.60−233%
FY2011$0.45n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26$0.05n/a−$0.11
Q1 FY26$0.01n/a−$0.27
Q4 FY25−$0.15n/a−$0.32
Q3 FY25−$0.02n/a−$0.24
Q2 FY25−$0.11n/a−$0.43
Q1 FY25−$0.04−110%−$0.52
Q4 FY24−$0.07n/a−$0.07
Q3 FY24−$0.21n/a−$0.10
Q2 FY24−$0.20n/a$0.04
Q1 FY24$0.41n/a$0.03
Q4 FY23−$0.10n/a−$0.61
Q3 FY23−$0.07n/a−$0.77

Against its peers

Companies in Biotechnology nearest Fennec Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
FENCFennec Pharmaceuticals−$0.11
PLXProtalix BioTherapeutics$0.23+283% a year
MGTXMeiraGTx$0.71
VCELVericel$0.46+283% a year
ADMAAdma Biologics$0.70−18% a year
Peer median$0.58

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Fennec Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.